Clinical Trial Update: ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring TLR8 stimulation followed by nucleos(t)ide analog discontinuation for chronic hepatitis B; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Hepatitis B, Chronic | Phase 2 | Status: UNKNOWN